Search Results Label

Seqirus Presents New Late-Breaking Data at ESWI 2020

https://www.seqirus.com/news/seqirus-presents-new-late-breaking-data-at-eswi-2020

Seqirus employs both egg and cell-based manufacturing systems to ensure the availability of our influenza vaccines. Learn more about our optimised technology.

https://www.seqirus.com/manufacturing/technologies

Seqirus Begins Shipping 2020/21 Influenza Vaccines to U.S. Market

https://www.seqirus.com/news/seqirus-begins-shipping-influenza-vaccines-to-us-market

Influenza is a common, highly contagious infection that can lead to life-threatening complications. Learn more about influenza and our cutting-edge vaccines.

https://www.seqirus.com/expertise/influenza

Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.

https://www.seqirus.com/expertise

Seqirus Presents Real-World Data for Cell-Based Quadrivalent Seasonal Influenza Vaccine (QIVc) at ESWI 2020

https://www.seqirus.com/news/seqirus-presents-real-world-data-for-cell-based-quadrivalent

First adjuvanted quadrivalent influenza vaccine receives EU approval

https://www.seqirus.com/news/first-adjuvanted-quadrivalent-influenza-vaccine--receives-eu-approval

This EU Flu Day, Seqirus confirms record number of influenza vaccines delivered across Europe to meet increased demand

https://www.seqirus.com/news/eu-flu-day-seqirus-confirms-influenza-vaccines-delivered-across-eu

Seqirus is a world leader in developing and producing influenza vaccines. Learn more about how we work with our partners to protect the global community.

https://www.seqirus.com/products

Seqirus is one of the largest influenza vaccine companies in the world, with state-of-the-art manufacturing facilities on three continents. Learn more.

https://www.seqirus.com/manufacturing/global-manufacturing-network